-
-
-
-
-
-
-
Novartis completes $12 billion Avidity Biosciences acquisition
-
-
-
-
-
-
-
Novartis CEO defends $12 billion deal for Avidity as 'appropriate risk to take'
-
-
-
-
-
-
-
Novartis buys Blackstone's Anthos for up to $3.1 billion
-
-
-
-
-
-
-
Novartis (NVS) to acquire MorphoSys (MOR) for EUR 68 per share, EUR 2.7bn in cash
-
-
-
-
-
-
-
Will this be the next obesity stock to be acquired?
-
-
-
-
-
-
-
Novartis buys Chinook for $3.5 billion in race to treat rare kidney disease
-
-
-
-
-
-
-
Novartis may divest generic unit Sandoz as price pressures mount
-
1,196,496 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


